Natraj Proteins

Who are the top shareholders of the Natraj Proteins?

The top shareholders of Natraj Proteins include promoter Sharad Kumar Jain with 6.38% and public shareholder Sangeetha S with 5.75%. Individual investors hold 50.62% of shares, with no pledged promoter holdings and minimal institutional involvement.

The top shareholders of Natraj Proteins include Sharad Kumar Jain, who is the promoter with the highest holding at 6.38%. The highest public shareholder is Sangeetha S, holding 5.75%. Additionally, individual investors collectively hold 50.62% of the company's shares. There are no pledged promoter holdings, and the company has minimal institutional involvement, with only one mutual fund scheme holding 1.9% and no foreign institutional investors.

Who are in the management team of Natraj Proteins?

As of March 2022, the management team of Natraj Proteins includes Kailash Chand Sharma (Chairman & Managing Director), Sharad Kumar Jain (Whole-time Director), and several independent directors, along with Pooja Agrawal as Company Secretary. They oversee the company's operations and strategic direction.

As of March 2022, the management team of Natraj Proteins includes the following individuals:<BR><BR>1. Kailash Chand Sharma - Chairman & Managing Director (Remuneration: Rs. 10.8 lacs)<BR>2. Sharad Kumar Jain - Whole-time Director (Remuneration: Rs. 6.6 lacs)<BR>3. Umesh Trivedi - Independent Director (Remuneration: Rs. 25.0 k)<BR>4. Pradeep Agrawal - Independent Director (Remuneration: Rs. 20.0 k)<BR>5. Namita Sharma - Director (Remuneration: Rs. 25.0 k)<BR>6. Rajendra Singh Tomar - Independent Director (Remuneration: Rs. 20.0 k)<BR>7. Pooja Agrawal - Company Secretary & Compliance Officer (Remuneration: Rs. 3.6 lacs)<BR><BR>This team is responsible for overseeing the operations and strategic direction of the company.

What does Natraj Proteins do?

Natraj Proteins Ltd is a micro-cap company in the edible oil industry, specializing in crude oil, refined oil, and de-oiled cake production. As of March 2025, it reported net sales of 23 Cr and a net profit of 1 Cr, with a market cap of Rs 15 Cr.

Overview:<BR>Natraj Proteins Ltd operates in the edible oil industry as a micro-cap company, specializing in the manufacture of crude oil, edible grade refined oil, and de-oiled cake.<BR><BR>History:<BR>Incorporated in November 1990, Natraj Proteins Ltd has maintained its focus on solvent extraction for oil production. The latest quarterly results reported net sales and profit for March 2025.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 23 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 1 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 15 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 21 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.15 <BR>Return on Equity: -4.33% <BR>Price-to-Book: 0.45<BR><BR>Contact Details:<BR>Address: Nagpur Kalan, Ordinance Factory Road Itarsi Madhya Pradesh : 461111 <BR>Tel: 91-07572-262636 <BR>Email: natrajproteins@rediffmail.com <BR>Website: http://www.natralproteins.com

Has Natraj Proteins declared dividend?

No Dividend History Available

Who are the peers of the Natraj Proteins?

Natraj Proteins' peers include Marico, Patanjali Foods, AWL Agri Business, Gokul Agro, Sundrop Brands, CIAN Agro, Kriti Nutrients, Ashiana Agro Ind, and Signature Green. In terms of management risk, growth, and capital structure, Natraj Proteins ranks below average compared to its peers, with a 1-year return of -12.26%.

Peers: The peers of Natraj Proteins are Marico, Patanjali Foods, AWL Agri Busine., Gokul Agro, Sundrop Brands, CIAN Agro, Kriti Nutrients, Ashiana Agro Ind, and Signature Green.<BR><BR>Quality Snapshot: Excellent management risk is observed at Marico, while Average management risk is found at Patanjali Foods, Gokul Agro, and Kriti Nutrients, and the rest. Below Average management risk is noted for AWL Agri Busine., CIAN Agro, and Sundrop Brands, and the rest. Growth is Excellent for Patanjali Foods, Gokul Agro, and CIAN Agro, while Average growth is seen at AWL Agri Busine., and the rest. Below Average growth is reported for Marico, Sundrop Brands, Kriti Nutrients, and Natraj Proteins. Capital Structure is Excellent at Marico and Kriti Nutrients, Good at Patanjali Foods, AWL Agri Busine., Gokul Agro, and Sundrop Brands, while Below Average is noted for CIAN Agro and Natraj Proteins.<BR><BR>Return Snapshot: CIAN Agro has the highest 1-year return at 1035.92%, while AWL Agri Busine. has the lowest at -27.28%. Natraj Proteins' 1-year return of -12.26% is better than AWL Agri Busine. but worse than all other peers. Additionally, the six-month return is negative for AWL Agri Busine., Gokul Agro, and Ashiana Agro Ind.

What is the technical trend for Natraj Proteins?

As of May 12, 2025, Natraj Proteins shows a mildly bearish trend with mixed signals: the weekly MACD is mildly bullish, the monthly MACD is bearish, and while the RSI is bullish on the monthly chart, Bollinger Bands and moving averages indicate bearishness across both daily and monthly charts.

As of 12 May 2025, the technical trend for Natraj Proteins has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish, suggesting mixed signals across time frames. The RSI shows no signal on the weekly chart but is bullish on the monthly, indicating potential strength in longer-term momentum. However, Bollinger Bands and moving averages are bearish on both daily and monthly charts, reinforcing the overall bearish sentiment. The KST is mildly bullish weekly but bearish monthly, further contributing to the mixed outlook. Overall, the current stance is mildly bearish, with key indicators showing divergence between short-term and long-term trends.

How big is Natraj Proteins?

As of 24th July, Natraj Proteins Ltd has a market capitalization of 16.00 Cr and reported Net Sales of 117.79 Cr, with a Net Profit loss of 1.46 Cr over the latest four quarters. The balance sheet for March 2024 shows Shareholder's Funds of 33.71 Cr and Total Assets of 77.83 Cr.

As of 24th July, Natraj Proteins Ltd has a market capitalization of 16.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Natraj Proteins reported Net Sales of 117.79 Cr. However, the company experienced a Net Profit loss of 1.46 Cr during the same period.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 33.71 Cr and Total Assets amounting to 77.83 Cr.

How has been the historical performance of Natraj Proteins?

Natraj Proteins has experienced significant fluctuations in financial performance, with declining net sales and operating income, but improved cash flow from operations. Despite a positive operating profit in Mar'25, the company continues to face challenges with negative profits before and after tax.

Answer:<BR>The historical performance of Natraj Proteins shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Natraj Proteins experienced a decline in net sales from 193.73 Cr in Mar'24 to 117.78 Cr in Mar'25, following a trend of decreasing sales since Mar'23 when it was 143.60 Cr. The total operating income mirrored this decline, dropping to 117.78 Cr in Mar'25 from 193.73 Cr in Mar'24. Raw material costs also decreased significantly, falling from 150.82 Cr in Mar'24 to 95.70 Cr in Mar'25. Despite this reduction in costs, the operating profit (PBDIT) turned positive at 1.61 Cr in Mar'25 after being negative in Mar'24. However, the company reported a profit before tax of -1.18 Cr in Mar'25, indicating ongoing challenges. The profit after tax also remained negative at -1.46 Cr. The total liabilities decreased from 77.83 Cr in Mar'24 to 58.63 Cr in Mar'25, while total assets also fell from 77.83 Cr to 58.63 Cr in the same period. Cash flow from operating activities showed improvement, reaching 21.00 Cr in Mar'25 compared to -5.00 Cr in Mar'24, but the net cash inflow/outflow remained at 0.00 Cr in Mar'25. Overall, Natraj Proteins has faced significant challenges in profitability and sales, while managing to improve cash flow from operations.

Is Natraj Proteins overvalued or undervalued?

As of November 17, 2025, Natraj Proteins is considered undervalued with a valuation grade shift to attractive, featuring a PE ratio of -9.07 and an EV to EBITDA of 34.42, significantly lower than peers like Gokul Agro and Guj. Ambuja Exp, despite a year-to-date return of -14.80% compared to the Sensex's 8.72%, indicating potential for recovery and growth.

As of 17 November 2025, the valuation grade for Natraj Proteins has moved from expensive to attractive, indicating a significant shift in its perceived value. The company is currently considered undervalued. Key ratios include a PE ratio of -9.07, an EV to EBITDA of 34.42, and a Price to Book Value of 0.49, which highlight its low valuation compared to earnings and assets.<BR><BR>In comparison to peers, Gokul Agro has a PE ratio of 20.15 and an EV to EBITDA of 10.23, while Guj. Ambuja Exp shows a PE of 22.97 and an EV to EBITDA of 11.75, both of which are considerably higher than Natraj Proteins. This suggests that Natraj is trading at a discount relative to its peers in the edible oil industry. Despite recent underperformance against the Sensex, with a year-to-date return of -14.80% compared to the Sensex's 8.72%, the attractive valuation suggests potential for recovery and growth.

When is the next results date for Natraj Proteins Ltd?

The next results date for Natraj Proteins Ltd is 13 February 2026.

The next results date for Natraj Proteins Ltd is scheduled for 13 February 2026.

Are Natraj Proteins Ltd latest results good or bad?

Natraj Proteins Ltd's latest results are concerning, showing a net loss of ₹1.65 crore for Q2 FY26, a 36.36% decline from the previous quarter, despite an 18.12% increase in net sales. The company's operating margin is negative, and its stock has underperformed significantly, indicating deteriorating financial health.

Natraj Proteins Ltd's latest results indicate a troubling financial performance. The company reported a net loss of ₹1.65 crore for Q2 FY26, which is a significant deterioration of 36.36% compared to the previous quarter. While there was an 18.12% year-on-year growth in net sales, reaching ₹26.92 crore, this growth has not translated into profitability, as the operating margin fell to a negative 3.79%, the worst in eight quarters.<BR><BR>The company's operational inefficiencies are evident, with expanding losses despite the increase in revenue. The proprietary Mojo score of 14 out of 100 places it firmly in "STRONG SELL" territory, reflecting fundamental weaknesses across various financial metrics. Additionally, the stock has underperformed significantly, trading down 16.67% over the past year, contrasting sharply with the Sensex's gain of 9.48% during the same period.<BR><BR>Overall, the results are concerning, highlighting persistent operational challenges and a lack of profitability, which suggests that the company's financial health is deteriorating rather than improving.

Should I buy, sell or hold Natraj Proteins Ltd?

Which are the latest news on Natraj Proteins?

Why is Natraj Proteins Ltd falling/rising?

As of 07-Apr, Natraj Proteins Ltd's stock price is at 36.50, down 2.54%. The decline is due to underperformance against its sector, being below its 200-day moving average, and a significant drop in investor participation.

As of 07-Apr, Natraj Proteins Ltd's stock price is currently at 36.50, reflecting a decrease of 0.95, or 2.54%. This decline can be attributed to several factors. Despite a positive performance over the past week and month, where the stock has risen by 4.85% and 17.17% respectively, it has underperformed its sector today by 1.9%. <BR><BR>Additionally, the stock's current price is lower than its 200-day moving average, indicating a potential bearish trend. There has also been a significant drop in investor participation, with delivery volume on April 6 falling by 83.16% compared to the 5-day average. This lack of engagement may contribute to the downward pressure on the stock price. <BR><BR>Overall, while Natraj Proteins Ltd has shown strong performance in the short term, the recent underperformance relative to its sector, lower moving averages, and decreased investor participation are key factors contributing to the current decline in its stock price.

Why is Natraj Proteins Ltd falling/rising?

As of 08-Apr, Natraj Proteins Ltd's stock price is at 36.40, down 0.27% and underperforming against the Sensex, which has risen 6.06%. The stock has seen a decline in investor participation, with an 82% drop in delivery volume, indicating a lack of confidence among investors.

As of 08-Apr, Natraj Proteins Ltd's stock price is currently at 36.40, reflecting a decrease of 0.1, or 0.27%. The stock has been underperforming relative to the benchmark Sensex, which has gained 6.06% over the past week, while Natraj Proteins Ltd has seen a decline of 0.27%. Additionally, the stock has experienced a consecutive fall over the last two days, resulting in a total decrease of 2.8% during this period.<BR><BR>Investor participation appears to be declining, as evidenced by a significant drop in delivery volume, which fell by 82% compared to the 5-day average. This reduction in trading activity may indicate a lack of confidence among investors. Although the stock's price is higher than its 20-day, 50-day, and 100-day moving averages, it is lower than its 5-day and 200-day moving averages, suggesting mixed performance trends.<BR><BR>Overall, the combination of recent price declines, underperformance against the benchmark, and falling investor participation contributes to the current downward movement in Natraj Proteins Ltd's stock price.

Why is Natraj Proteins Ltd falling/rising?

As of 09-Apr, Natraj Proteins Ltd's stock price is rising to Rs 37.10, reflecting a 2.88% increase. This rise is due to its outperformance against peers, a recovery in investor sentiment after prior declines, and maintaining above key moving averages, despite mixed long-term performance.

As of 09-Apr, Natraj Proteins Ltd's stock price is rising, currently at Rs 37.10, reflecting a change of 1.04 (2.88%) upward. This increase can be attributed to several factors. Firstly, the stock has outperformed its sector by 4.16%, indicating a stronger performance relative to its peers. Additionally, there has been a trend reversal as the stock gained after two consecutive days of decline, suggesting a recovery in investor sentiment. <BR><BR>The stock also touched an intraday high of Rs 37.1, reinforcing the positive momentum. Furthermore, despite a decrease in delivery volume by 58.34% against the 5-day average, the stock remains above its 5-day, 20-day, 50-day, and 100-day moving averages, which typically indicates a bullish trend. <BR><BR>However, it is important to note that the stock's performance over longer periods shows mixed results, with a year-to-date increase of 15.94% compared to a decline in the benchmark Sensex by 10.08%. Overall, the current rise in Natraj Proteins Ltd's stock price can be attributed to its recent outperformance and recovery from previous declines.